Subject: Frequency Exchange news release
Word Document
File: '\\swfile\EmailIn\20251219 053200 Attachment 20251219 - 20. FREQ Appoints Sammy Chow to Advisor Board.docx'
FREQUENCY EXCHANGE CORP. APPOINTS SAMMY CHOW TO ADVISORY BOARD
FOR IMMEDIATE RELEASE
Vancouver, British Columbia - December 19, 2025 - Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) ("Frequency Exchange" or the "Company") is pleased to announce the appointment of Sammy Chow to its Advisory Board.
Sammy Chow brings more than two decades of leadership experience in finance, operations, corporate development, and strategy. He has held senior executive roles including Chief Financial Officer and Chief Operating Officer across sectors such as manufacturing, technology, and renewable energy.
Mr. Chow has worked with both startups and global organizations, including Fortune 500 companies, across Asia, the United States, and Canada. He has led and supported initiatives involving capital investments, market entry, and strategic partnerships resulting in more than $1 billion in successful transactions.
"Sammy adds valuable capital markets and operational depth to our leadership group," said Stephen Davis, CEO of Frequency Exchange Corp. "His track record working across growth-stage and global enterprises brings the type of discipline and insight we believe is essential as we scale."
Sammy holds an MBA from the University of Ottawa, a Bachelor of Commerce from the University of British Columbia, and is a Chartered Financial Analyst (CFA).
About the Company
Frequency Exchange Corp. (TSXV: FREQ; OTC: FRECF) is the parent company of FREmedica Technologies Inc., a developer and commercializer of frequency-based digital wellness technologies. The Company's flagship product, NIKKI, delivers programmable frequency wellness programs designed to support cellular communication and overall wellbeing.
Originally developed to support those with Lyme disease, the NIKKI platform has evolved to address broader use cases, including sleep, pain, energy, immune support, and athletic recovery. The Company's technology is supported by ongoing testing and quality-of-life evaluations.
www.WeAreNikki.com
www.FrequencyExchangeCorp.com
For more information, please contact:
Frequency Exchange Corp. FREmedica Technologies Inc.
Stephen Davis Nicole Sullivan
CEO & Director President
250-732-7170 Nicole.sullivan@wearenikki.com
Cautionary Note Regarding Forward-Looking Information
Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. All statements, other than statements of historical fact, included in this news release are forward-looking statements that involve risks and uncertainties. In particular, forward-looking information includes, but is not limited to, statements with respect to the Company's use of proceeds from the private placement. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Exchange nor its Regulation Services Provider (as that term is defined in policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
© 2026 Canjex Publishing Ltd. All rights reserved.